T he functional gastrointestinal disorders (FGIDs) are common conditions with an overall FGID prevalence burden estimated at approximately one-third of the population. 1 By definition, functional gut conditions are not associated with any identifiable pathology, although putative mechanisms have been identified in subsets of patients. [2] [3] [4] Neither their etiology nor maintenance are well understood, although they are thought to be of heterogeneous origin, which may include structural and psychological causes. 5, 6 The role of psychological factors has been studied extensively including data indicating that traumatic events, particularly sexual and physical abuse during childhood, 7 are associated with elevated rates of FGIDs as are higher levels of neuroticism. 8 Data from our own group are supportive of the directional hypothesis that abuse during childhood is associated with elevated neuroticism and FGIDs in adulthood. 9 FGIDs are strongly associated with anxiety and depression in cross-sectional studies. 10 Longitudinal studies to date have been inconclusive with some evidence suggesting a bidirectional pathway. 11 However, most longitudinal research is of limited duration of follow-up and data collection often commences after FGID and/or psychological conditions have already occurred, because the subject may or may not have been aware or recall the initial onset.
Whether or not psychological conditions and FGIDs are causally related requires one to understand the order of incidence 12 because outcome cannot precede cause. In cases where psychological condition is first recognized before an FGID this at least establishes the possibility of a "brain to gut pathway" in the association, whereas the reverse order suggests a "gut to brain pathway," although order of incidence is a necessary but not sufficient condition to establish causality. A third possibility is that both FGIDs and psychological disorders arise from a common cause, which accounts for their apparent association, although there are no data to support this hypothesis. Given the heterogeneity of FGIDs 13 it is possible that the causal pathway varies between individuals.
An earlier study by Sykes et al 14 concluded that, depending on the specific psychological condition, between 60% (depression) and 80% (anxiety) of individuals reported onset of the psychological condition before irritable bowel syndrome (IBS). These authors cite this as evidence of a brain to gut pathway and potentially suggests that anxiety is more likely to precede FGID onset than depression. Weaknesses of this study are relatively small sample size (n ¼ 188) and use of patient recall to determine date of disease onset. Recall has been shown to be unreliable in epidemiologic studies. 15 Similar findings have been made by earlier studies, 16 although these also had methodological limitations and even smaller sample size.
In a recently published small study (n ¼ 90) with baseline and 1 year follow-up Koloski et al 17 identified two-thirds of individuals with mood disorder but no FGID who met criteria for an FGID 1 year later and onethird of individuals with FGID but no mood disorder at baseline who developed a mood disorder 1 year later.
Despite the general acceptance of IBS and other FGIDs as heterogeneous disorders and several studies that have sought to identify the order of incidence of psychological and gastrointestinal symptoms in these patients there is no clear insight into what percentage of patients may have symptoms that originated in the brain versus the gut. We therefore sought, using 2 independent studies, to identify the proportion of individuals in whom 1 or more FGID preceded mood or anxiety disorder diagnoses and vice versa. Based on the Sykes data on order of incidence we hypothesized that approximately two-thirds of individuals would be consistent with a brain-origin, whereas one-third would be consistent with a gut-origin direction. We also sought to determine whether the order of incidence was moderated by any of several patient characteristics.
Methods
We report on analyses of 2 independent studies, a general practice medical record review conducted in the United Kingdom and a random population sample conducted in Australia. Between them these studies provide insights from 2 key populations: health care seekers and the general population. Although there are important sampling differences between these 2 populations a contrast of the 2 provides useful insight into the generalizability of our findings. The 2 study outlines discussed next provide brief synopses and fuller details are provided in the Supplementary Methods.
Study 1: General Practice Medical Record Review
Data acquisition. Subjects were drawn from general practices across the United Kingdom 18 with data captured from electronic medical records via The Health Improvement Network, which has been shown to provide valid diagnostic records. 19 The Health Improvement Network follows equivalent methodology to the General Practice Research Database, which has also demonstrated diagnostic validity. 20 Patient initial identification and diagnosis codes. The disease groups of interest were identified from Read codes as are commonly used in the United Kingdom by general practitioners. Because it was not expected that general practitioners would always note formal diagnoses, such as IBS, some diagnoses considered to be reliable proxies for these diagnoses were used. Full details, including specific Read and British National Formulary codes, are provided in the Supplementary Methods.
Determination of order of incidence. The order of incidence of FGID and mood or anxiety disorder was determined by which appeared in the medical record first. The interval between first appearance of FGID and mood or anxiety disorder (and vice versa) was calculated as a measure of latency between these events.
Inclusion criteria. Because the aim of the study was to ascertain the order of incidence of FGID and mood or anxiety disorder diagnoses, only individuals identified as receiving both diagnoses and therapies for at least 1 FGID and at least 1 mood or anxiety disorder were included. Across the 3 FGIDs this yielded 5209 unique individuals. After excluding 243 individuals whose FGID and mood/anxiety dates of incidence were close, the remaining 4966 patients constitute the primary sample used in this study.
Moderation of order of incidence. Possible moderation of the order of incidence by factors known to be associated with FGIDs and available in the database included gender [21] [22] [23] and socioeconomic disadvantage 24 (Townsend score 25 ) and some socioeconomic background.
Statistical analysis. The proportion of patients in whom record of psychological disorder precedes record of a given FGID is reported along with exact 95% confidence interval (CI). Moderation of this order by the factors described previously was assessed via unconditional logistic regression in which the odds of mood or anxiety disorder diagnosis preceding FGID diagnosis was the outcome.
Study 2: Australian General Population Sample
This sample has been described previously 11 but, in brief, represents a population sample from an area in western Sydney, Australia, which was shown to be broadly representative of the Australian population.
Study design and measures. The sample (n ¼ 1002, from n ¼ 1997 contacted) was obtained by random selection from the electoral roll of the division of Lyndsey. FGID (IBS and functional dyspepsia) were evaluated according to Rome II criteria, 26 which were current at the time of this study, whereas mood disorders were evaluated using the Delusion Symptom States Inventory, 27 which yields separate scores for anxiety and depression.
Determination of order of incidence. Order of incidence could be determined among individuals who were either free of FGID or mood disorder at baseline but developed either FGID or mood disorder at 12-year follow-up.
Moderation of order of incidence. To determine whether the order of incidence in the study of FGIDs and mood disorders might be associated with particular psychological traits the brain-gut and gut-brain cohorts were compared with respect to age, gender, personality, baseline anxiety, depression, General Health Questionnaire, and quality of life.
Results

Study 1: UK General Practice Medical Records
Patient disposition. As noted, 4966 patients met all inclusion criteria, including diagnoses and prescriptions for 1 or more FGIDs. A total of 3007 patients met all inclusion criteria and yielded diagnoses of IBS; this was true of 2929 for dyspepsia and 1049 for constipation.
Demographics. The samples were predominantly female, as expected, with females making up 79% of the IBS group, 74% of the dyspepsia group, and 75% of the constipation group. Distribution of Townsend scores was close to that expected from the UK general population (uniform) except for the IBS sample in which the highest Townsend quintile only made up 14% of that sample and the most common area of residence was urban townships >10,000 population, as is typical of the UK population.
Order of diagnoses. The dates of first FGIDs and mood or anxiety disorder diagnoses in the 3 subsamples cover an average period of 13.1 years (standard deviation, 7.3). During this period the first mood or anxiety disorder record preceded the first FGID record in a clear majority of patients (Table 1) for any FGID and for individual FGIDs. The proportion of the any FGID that preceded mood or anxiety disorders was lower than for any specific FGIDs because the probability of FGID being first reported increases with the number of different FGIDs considered, because the first FGID date is the minimum of the individual disease dates rather than the average. Due to the large sample size the percentages of psychological then FGID record has quite narrow CIs for all FGID groupings. Although Table 1 excludes individuals who were diagnosed simultaneously with an FGID and a psychological disorder, a small number of individuals have first recorded diagnoses that are quite close together. The further exclusion of individuals whose first recorded diagnoses are within 1 month of each other changes the reported rate at which psychological diagnoses precede gastrointestinal by AE1%. Moderation of order of diagnosis ( Table 1 ). The order of diagnosis during the follow-up period showed some evidence of moderation by socioeconomic disadvantage (Townsend score) for any FGID and IBS. The rate at which mood or anxiety disorder diagnoses precede FGID diagnoses was increased in areas of higher socioeconomic disadvantage for both IBS (73% in the lowest quintile, 83% in the highest quintile) and any FGID (62% in the lowest quintile, maximum of 69% in the 4th quintile). The order of diagnoses for any FGID was also moderated by the number of FGID diagnoses found in the medical record. Multivariate logistic regression revealed that female gender (odds ratio [OR], 1.31; 95% CI, 1.13-1.53) and higher Townsend score (OR, 1.08; 95% CI, 1.03-1.13) both increased the odds of mood or anxiety disorder diagnosis preceding FGID diagnosis, whereas multiple FGIDs decreased the odds (OR, 0.81; 95% CI, 0.71-0.92).
Interval between diagnoses. Although there was considerable interindividual variation, the interval between first mood or anxiety and FGID diagnosis was, on average, quite long and is displayed graphically in Figure 1A . When mood or anxiety disorder diagnosis preceded FGID diagnosis the interval had a median (25th-75th percentiles) of 3.5 years (1.1-7.6) for any FGID, 5.5 years (2.2-10.1) for IBS, 4.0 years (1.5-8.4) for dyspepsia, and 7.0 years (2.9-13.4) for constipation. In contrast, when an FGID diagnosis preceded mood or anxiety disorder diagnosis ( Figure 1B ) the median interval ranged from an average of 1.8 years (0.6-4.2) for any FGID, 1.8 years (0.6-4.5) for IBS, 1.5 years (0.5-3.6) for dyspepsia, and 1.9 years (0.5-4.5) for constipation. Hence mood or anxiety disorder diagnoses seem to follow FGID diagnoses more quickly than vice versa.
Study 2: Random Community Sample
Of 1002 individuals who responded at both baseline and 12-year follow-up, 642 did not qualify for both FGID and anxiety/depression and a further 217 qualified for either none or both FGID and anxiety/depression at baseline. For both of these subgroups the order of incidence of FGIDs and anxiety/depression could not be determined, leaving a sample of 143 community individuals for whom order of appearance of FGIDs and anxiety/depression could be established. In this group 47% (95% CI, 38%-55%; n ¼ 67) qualified for anxiety/ depression at baseline then FGID at follow-up and 53% (95% CI, 45%-62%; n ¼ 76) qualified for FGID at baseline then anxiety/depression at follow-up.
Several psychological traits recorded at baseline were found to discriminate between brain-gut and gut-brain order (Table 2 ). In addition, a combination of baseline anxiety (OR, 2.1; 95% CI, 1.2-3.6; P ¼ .005), depression (OR, 1.5; 95% CI, 1.1-2.1; P ¼ .01), and neuroticism (OR, 0.5; 95% CI, 0.3-1.0; P ¼ .04) provided excellent discrimination between brain-gut and gut-brain order of incidence (area under the curve, 0.99).
Discussion
We set out to describe the temporal order of FGID diagnoses and mood disorders in 2 separate studies of quite different populations. One represented health care seekers in an otherwise unselected general practice population, whereas the other drew on a random community sample. The contrast of these 2 disparate samples yields insight into the generalizability of the findings.
Among health care seekers anxiety/depression precede FGIDs by a considerable majority (66%), whereas among the random population sample the split was approximately even with 47% of respondents reporting anxiety/depression before FGID. It is possible that some fraction of the gastrointestinal disorder diagnoses is caused by central nervous system medication use for psychiatric disorders or other indications. This is unlikely to account for other FGIDs, however, such as IBS and functional dyspepsia. In contrast to a previous study 28 we did not find that anxiety disorders were more likely to precede FGIDs than depression among general practice patients, although the time frames and diagnostic definitions of our 2 studies are not completely comparable. These finding are consistent with data from studies of the influence of childhood abuse on subsequent adult FGID onset. Childhood abuse has been associated with trait anxiety 29 suggesting a chronic rather than acute process in the brain-to-gut direction. In contrast, among individuals in whom an FGID is recorded before a mood or anxiety disorder the latency is generally around half that length, suggesting that the influence of FGID symptoms on mood or anxiety is relatively rapid. The long latency between onset of mood or anxiety disorder and FGID offers an opportunity to potentially prevent the onset of gastrointestinal symptoms or to prevent them from becoming sufficiently severe to lead to an FGID with its related impact on the individual's quality of life.
The present data are consistent with the findings of Koloski et al 11 who found that the association is bidirectional because individuals free of FGIDs at baseline were more likely to develop an FGID 12 years later if they had higher affective scores and that those free of affective disorder at baseline were more likely to develop one if they had an FGID. Our data are also consistent with the findings of Sykes et al 14 described previously. The complexity of the brain-to-gut and gut-to-brain pathways is illustrated by our consideration of whether the natural history might be altered by 1 or more of several factors recorded in the medical record (Table 1) . Of these, socioeconomic disadvantage showed the clearest influence with patients living in areas of higher disadvantage being more likely to have a mood or anxiety disorder diagnosis precede FGID diagnosis than those in less disadvantaged areas for both IBS and constipation. Socioeconomic disadvantage is associated with higher level of psychological morbidity in general, 30 which may explain its association with a higher chance of psychiatric diagnosis preceding FGID diagnosis. In contrast, FGID diagnosis was more likely to precede mood or anxiety disorder diagnoses for patients in whom multiple FGIDs were recorded. This may indirectly suggest that in some individuals the presence of multiple FGID symptoms (and/or their underlying peripheral mechanisms, which are yet to be identified) drives the patients' psychological symptoms.
This study has several limitations. First, the true order of incidence could only be established without doubt through a prospective birth cohort study. However the triangulation between the findings of studies 1 and 2 the Koloski et al 17 and Sykes et al 28 studies provides considerable confidence that these findings are not driven by methodological issues. As explained in detail in the methods section, we have attempted to add rigor to the disease definition by adding the requirement that as well as a diagnosis being recorded a potentially relevant medication was prescribed. This would suggest that the diagnosis was not a transitory or speculative entry, and long-term follow-up in general practice should have identified most serious organic gut diseases making misclassification of functional gastrointestinal diagnoses unlikely. It is known that Rome criteria are rarely used in primary care. 31 We believe these limitations are substantially outweighed by several strengths of this study. These include large sample size compared with any tertiary care study and the fact that our sample is likely to be more representative for patients with FGID in general compared with the highly selected tertiary care samples that are often characterized by multiple comorbidities. Because general practitioners provide most patient care for (functional) gastrointestinal disorders in the United Kingdom and many other countries their medical records provide a unique insight into this question addressed in this paper. Furthermore, the long naturalistic follow-up of this study and "inclusion" of subjects at the of moment diagnosis has the advantage of vastly reducing the problem of recall bias that is present in many tertiary care studies where subjects are included at various time points after having first received an FGID and/or psychiatric diagnosis.
In summary, our data suggest that psychological disorders precede gastrointestinal in most health care seekers whereas, the order is more evenly split in the general population. Our data also link with population studies showing the association between socioeconomic factors, FGID incidence, and psychological morbidity, 9, 24, 32, 33 suggesting that socioeconomic disadvantage may be partly responsible for driving the brain-to-gut pathway. However, the manifestation of FGIDs in patients with psychological disturbances and the manifestation of psychological disturbances in patients with FGID is not simply a coincidence.
Supplementary Material
Note: To access the supplementary material accompanying this article, visit the online version of Clinical Gastroenterology and Hepatology at www.cghjournal.org, and at http://dx.doi.org/10.1016/j.cgh.2016.12.032. 18 with data captured from electronic medical records via The Health Improvement Network (THIN). THIN collects raw data from practices, queries possible data errors, and resolves fields pertaining to diagnoses, prescriptions, and referrals to a common basis for comparability across practices. It has been shown to be broadly representative of the demographics of the United Kingdom. 18 The diagnostic records in THIN have been shown to be valid. 19 THIN follows equivalent methodology to the General Practice Research Database, which has also demonstrated diagnostic validity. 20 This procedure was approved by the National Health Service (UK) South-East Multi-Centre Research Ethics Committee. Funding to obtain access to the data was provided by a grant from the Psychology Department at Macquarie University. Diagnoses are coded according to the Read code system 34 and prescriptions are coded according to the British National Formulary system. 35 THIN ensures high data quality and engages with practices to correct errors. Data of certified quality are flagged as such. Only data with an explicit quality flag were used for the purpose of this study.
Patient Initial Identification and Diagnosis Codes
Patients were identified in the database who met the following criteria: had either a record of 1 or more Read codes determined to be indicative of irritable bowel syndrome (IBS), dyspepsia, or constipation (see later); and had at least 5 years of continuous medical record.
It is important to note that the study uses a general practitioner definition of the functional gastrointestinal disorders (FGIDs) considered rather than the standard Rome criteria 36 because it is known that the Rome criteria are not generally used in the general practice setting. 31 
Gastrointestinal Disease Definition
Because it is possible that general practitioners will not code diagnoses of IBS and functional dyspepsia (FD) in those terms, the Read code term list was searched for additional terms that might be indicative of these disorders. Examples of indicative diagnoses considered are spastic colon in the case of IBS and impaction for chronic idiopathic constipation. For IBS the Read codes used were 14CF.00, J521000, J521.00, J521.11, and J521. 13 were considered indicative of constipation because they refer to intestinal or fecal impaction. Several codes explicitly indicate chronic constipation (E264500, J520.00, J520100, J520200, J520400) and a single record of these codes has been taken as sufficient for membership of the chronic idiopathic constipation group, whereas more than 1 medical record was required for the other codes specified, which are less clearly indicative of chronic constipation. Although we interpret these disease codes as representing a FGID based on the low prevalence of organic disease in the community, 37 there is no explicit indication of cause or etiology in the medical record. However, the extremely large sample size means that it is likely that the small number of organic cases will be vastly outweighed by most true FGID cases and the long followup period renders it unlikely that many organic cases will have been missed.
Anxiety and Depression Definition
Anxiety disorder diagnoses were flagged only through direct indications of these disorders, such as code E200200 (generalized anxiety disorder). Similarly, depressive disorder diagnoses were flagged through direct indications, such as E113.00 (recurrent major depressive episode). A full listing is provided in Supplementary Table 1.
Medical Therapies
To ensure that a diagnosis was not speculative we also required confirmation through patients having been prescribed medication that is plausibly related to the diagnosis. For IBS this was any medication in the British National Formulary (BNF) category 1.2 (antispasmodics and other drugs altering gut motility), for dyspepsia BNF categories 1.1 (dyspepsia and gastroesophageal reflux disease) or 1.3 (antisecretory drugs and mucosal protectants, which includes prokinetic drugs), and for constipation BNF category 1.6 (laxatives). For mood and anxiety disorders a broad definition was adopted in which any central nervous system therapy (BNF 4.0) was considered relevant. Although none of these medication categories would in themselves be indicative of the FGID or mood/anxiety disorders studied, when taken together with the diagnostic codes listed previously they provide strong evidence. It is an acknowledged limitation of the database that we cannot link a prescription directly to a diagnosis and we therefore need to acknowledge that it is our assumption that these medications are given for the FGIDs or psychiatric disorders studied.
The approach adopted ensures that only relevant manifestations of psychiatric or FGID were counted because the initiation of treatment indicates that the respective symptoms were relevant.
Determination of Order of Incidence
A given FGID was determined to have been diagnosed before mood or anxiety disorders if the first date of either diagnosis or relevant prescription was before the first date of either diagnosis or relevant prescription for a mood or anxiety disorder. A mood or anxiety disorder was determined to have been diagnosed before a given FGID if the first date of either diagnosis or relevant prescription was before the first date of either diagnosis or relevant prescription for the FGID. The interval between first event (mood or anxiety disorder diagnosis or FGID diagnosis) and second has been calculated in years to enable comment on whether the diagnosis of the second disorder was truly distinct from the first. Individuals in whom mood or anxiety disorder and FGID were diagnosed simultaneously were excluded because order cannot be determined. In a sensitivity analysis, individuals in whom the date of first mood or anxiety disorder and FGID diagnosis were within 1 month of each other were also excluded.
Inclusion Criteria
Because the aim of the study was to ascertain the order of incidence of FGID and mood or anxiety disorder diagnoses, only individuals identified as receiving both diagnoses and therapies for at least 1 FGID and at least 1 mood or anxiety disorder were included. Across the 3 FGIDs this yielded 5209 unique individuals. Of these individuals a total of 243 received their first FGID diagnosis or prescription on the same day as their first mood or anxiety disorder diagnosis or prescription. Hence, for these individuals the order of incidence cannot be determined and were therefore excluded. The remaining 4966 patients constitute the primary sample used in this study. When considering the order of specific FGID and psychological disorder diagnoses the available sample is smaller because the diagnosis/prescription inclusion criterion applies to each specific FGID rather than any FGID.
Moderation of Order of Incidence
Although the order of incidence of FGID and mood or anxiety disorder diagnoses might be determined by biologic and psychological factors it was also hypothesized that external factors might affect the order. Factors known to be associated with FGIDs and available in the database were gender [21] [22] [23] and socioeconomic disadvantage 24 (Townsend score 25 ). The percentage of residents in the patient's locality that were white and, separately, black were included as proxies for other social phenomena. These indices were obtained from 2001 UK census. Although the rural/urban nature of an area is not specifically known to be associated with FGIDs, we speculated that patient and/or general practitioner characteristics might be associated with differential reporting/recognition of these disorders. Townsend score 25 and percentage black and white residents are recorded according to the national quintile of the patient's area of residence. Rurality is measured on a 1-to-7-point scale where lower scores are more sparsely populated areas and higher scores indicate more populated locations.
A secondary analysis is reported on whether the order of first recorded psychological and FGID conditions depends on whether the psychological condition is anxiety or depression. Because psychoactive medications cannot be confidently assumed to be for either anxiety or depression this analysis has been undertaken considering diagnosis records only. For this analysis the inclusion criterion was having both a gastrointestinal diagnosis and either an anxiety or depression diagnosis. Because some patients only have one or the other the sample sizes for this analysis are slightly smaller than for the primary analysis.
Statistical Analysis
The proportion of patients in whom record of psychological disorder precedes record of a given FGID is reported along with exact 95% confidence intervals. Moderation of this order by the factors described previously was assessed via unconditional logistic regression in which the odds of mood or anxiety disorder diagnosis preceding FGID diagnosis was the outcome.
Study 2: Australian General Population Sample
Study Design and Measures
The sample was obtained by random selection from the electoral roll of the division of Lyndsey. Individuals who completed an initial survey of gastrointestinal symptoms, mood disorders in 1997 were contacted 12 years later and 1002 agreed to participate in the follow-up for a response rate of 60%. FGID (IBS and FD) were evaluated according to Rome II criteria, 26 which were current at the time of this study, whereas mood disorders were evaluated using the Delusion Symptom States Inventory (DSSI 27 ), which yields separate scores for anxiety and depression. Personality domains of neuroticism and extroversion were measured from the Eysenck questionnaire, 38 general psychological health from the General Health Questionnaire, 39 and quality of life was measured via the Short Form-12. 40 
Determination of Order of Incidence
Order of incidence of FGIDs and mood disorders was evaluated by forming 2 cohorts. Cohort 1 were individuals who at baseline reported elevated scores (!4) on the DSSI but did not qualify for an FGID; cohort 2 was composed of individuals who qualified for 1 or more FGIDs but did not yield elevated scores (!4) on the DSSI. Individuals in cohort 1 who qualified for an FGID at follow-up are labelled "brain-gut" direction, and individuals in cohort 2 who yielded elevated DSSI scores at follow-up are labelled "gut-brain" direction. The order of incidence could only be evaluated for individuals in cohorts 1 and 2 who developed the alternate condition at follow-up, which accounts for 143 of the total sample.
Moderation of Order of Incidence
To determine whether the order of incidence in the study of FGIDs and mood disorders might be associated with particular psychological traits the brain-gut and gut-brain cohorts were compared with respect to age, gender, personality, baseline anxiety, depression, General Health Questionnaire, and quality of life. Descriptive statistics are reported for the 2 orders, which are compared formally using the Mann-Whitney test for quantitative measures and the Pearson chi-square test for gender.
